These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7865284

  • 21. Mucosal immune system of the human genital tract.
    Mestecky J, Fultz PN.
    J Infect Dis; 1999 May; 179 Suppl 3():S470-4. PubMed ID: 10099122
    [Abstract] [Full Text] [Related]

  • 22. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y, Kiyono H.
    Rev Med Virol; 2003 May; 13(5):293-310. PubMed ID: 12931340
    [Abstract] [Full Text] [Related]

  • 23. Progress towards an AIDS mucosal vaccine: an overview.
    Yuki Y, Nochi T, Kiyono H.
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S35-44. PubMed ID: 17652028
    [Abstract] [Full Text] [Related]

  • 24. [Immunity of the female genital tract mucosa and mechanisms of papillomavirus evasion].
    Riethmuller D, Seilles E.
    J Gynecol Obstet Biol Reprod (Paris); 2000 Dec; 29(8):729-740. PubMed ID: 11139708
    [Abstract] [Full Text] [Related]

  • 25. Mucosal responses to parenteral and mucosal vaccines.
    Kaul D, Ogra PL.
    Dev Biol Stand; 1998 Dec; 95():141-6. PubMed ID: 9855424
    [Abstract] [Full Text] [Related]

  • 26. Protecting the initial site of viral entry: an alternative HIV vaccine target.
    Lopalco L, Bomsel M.
    Expert Rev Vaccines; 2011 Sep; 10(9):1253-6. PubMed ID: 21919613
    [No Abstract] [Full Text] [Related]

  • 27. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
    Belyakov IM, Ahlers JD.
    Trends Immunol; 2008 Nov; 29(11):574-85. PubMed ID: 18838298
    [Abstract] [Full Text] [Related]

  • 28. Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.
    Wright PF, Mestecky J, McElrath MJ, Keefer MC, Gorse GJ, Goepfert PA, Moldoveanu Z, Schwartz D, Spearman PW, El Habib R, Spring MD, Zhu Y, Smith C, Flores J, Weinhold KJ, National Institutes of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
    J Infect Dis; 2004 Apr 01; 189(7):1221-31. PubMed ID: 15031791
    [Abstract] [Full Text] [Related]

  • 29. Induction of dendritic cell-mediated immune responses against HIV-1 by antigen-capturing nanospheres in mice.
    Kawamura M, Wang X, Uto T, Sato K, Ueno M, Akagi T, Hiraishi K, Matsuyama T, Akashi M, Baba M.
    J Med Virol; 2005 May 01; 76(1):7-15. PubMed ID: 15778965
    [Abstract] [Full Text] [Related]

  • 30. HIV vaccine and genital secretory immune response.
    Stefanache-Guihard AI.
    Rom J Virol; 1995 May 01; 46(1-2):85-98. PubMed ID: 9106405
    [Abstract] [Full Text] [Related]

  • 31. New perspectives in mucosal immunity with emphasis on vaccine development.
    McGhee JR, Fujihashi K, Xu-Amano J, Jackson RJ, Elson CO, Beagley KW, Kiyono H.
    Semin Hematol; 1993 Oct 01; 30(4 Suppl 4):3-12; discussion 13-5. PubMed ID: 8303308
    [Abstract] [Full Text] [Related]

  • 32. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts.
    Klavinskis LS, Barnfield C, Gao L, Parker S.
    J Immunol; 1999 Jan 01; 162(1):254-62. PubMed ID: 9886393
    [Abstract] [Full Text] [Related]

  • 33. Mucosal immunity: induction, dissemination, and effector functions.
    Brandtzaeg P.
    Scand J Immunol; 2009 Dec 01; 70(6):505-15. PubMed ID: 19906191
    [Abstract] [Full Text] [Related]

  • 34. Genital CD8+ T cell response to HIV-1 gag in mice immunized by mucosal routes with a recombinant simian adenovirus.
    de Souza AP, Haut LH, Silva R, Ferreira SI, Zanetti CR, Ertl HC, Pinto AR.
    Vaccine; 2007 Jan 02; 25(1):109-16. PubMed ID: 16914235
    [Abstract] [Full Text] [Related]

  • 35. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
    Huang XG, Xu JQ, Ren L, Qiu C, Zhang N, Liu LX, Wan YM, Peng H, Shao YM.
    Zhonghua Yi Xue Za Zhi; 2006 Nov 28; 86(44):3109-13. PubMed ID: 17313761
    [Abstract] [Full Text] [Related]

  • 36. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
    Kaneko H, Bednarek I, Wierzbicki A, Kiszka I, Dmochowski M, Wasik TJ, Kaneko Y, Kozbor D.
    Virology; 2000 Feb 01; 267(1):8-16. PubMed ID: 10648178
    [Abstract] [Full Text] [Related]

  • 37. [Properties of mucosal antibodies].
    Quan C, Decroix N, Bouvet JP.
    J Soc Biol; 2001 Feb 01; 195(2):119-24. PubMed ID: 11723823
    [Abstract] [Full Text] [Related]

  • 38. The secretory IgA system.
    Hanson LA, Andersson B, Carlsson B, Dahlgren U, Mellander L, Porras O, Svanborg Edén C, Söderström T.
    Klin Padiatr; 1985 Feb 01; 197(4):330-3. PubMed ID: 4046490
    [Abstract] [Full Text] [Related]

  • 39. Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine.
    Hamajima K, Hoshino Y, Xin KQ, Hayashi F, Tadokoro K, Okuda K.
    Clin Immunol; 2002 Jan 01; 102(1):12-8. PubMed ID: 11781062
    [Abstract] [Full Text] [Related]

  • 40. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR, Berraondo P, Crettaz J, Ochoa L, Vera M, Lasarte JJ, Vales A, Van Rooijen N, Ruiz J, Prieto J, Zulueta J, González-Aseguinolaza G.
    Vaccine; 2005 Feb 03; 23(11):1384-92. PubMed ID: 15661387
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.